Advanced search
Publication Cover
Epigenetics Volume 6, 2011 - Issue 8
Submit an article Journal homepage
803
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma

Heather H. Nelson Division of Epidemiology and Community Health; Brown University, Providence, RI USACorrespondence[email protected]
,
Lindsay M. Almquist Division of Epidemiology and Community Health; Brown University, Providence, RI USA
,
Jessica L. LaRocca Departments of Pathology and Laboratory Medicine; Brown University, Providence, RI USA
,
Silvia L. Plaza Departments of Pathology and Laboratory Medicine; Brown University, Providence, RI USA
,
Geralyn M. Lambert-Messerlian Departments of Pathology and Laboratory Medicine; Brown University, Providence, RI USA
,
David J. Sugarbaker Division of Thoracic Surgery Brigham and Women’s Hospital; Harvard Medical School; Boston, MA USA
,
Raphael Bueno Division of Thoracic Surgery Brigham and Women’s Hospital; Harvard Medical School; Boston, MA USA
,
John J. Godleski Department of Environmental Health, Harvard School of Public Health; Boston, MA USA
,
Carmen J. Marsit Departments of Pathology and Laboratory Medicine; Brown University, Providence, RI USA
,
Brock C. Christensen Departments of Pathology and Laboratory Medicine; Brown University, Providence, RI USA
&
Karl T. Kelsey Departments of Pathology and Laboratory Medicine; Brown University, Providence, RI USA
 show all
Pages 1029-1034 | Received 11 Mar 2011, Accepted 10 Jun 2011, Published online: 01 Aug 2011

References

  • Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology and End Results Program data for 1973 through 2003. Am J Epidemiol 2004; 159:107 - 112
  • Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999; 79:666 - 672
  • Gaafar RM, Eldin NH. Epidemic of mesothelioma in Egypt. Lung Cancer 2005; 49:17 - 20
  • Musk AW, de Klerk NH. Epidemiology of malignant mesothelioma in Australia. Lung Cancer 2004; 45:21 - 23
  • Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353:1591 - 1603
  • Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas and ovarian cancers. Proc Natl Acad Sci USA 1996; 93:136 - 140
  • Beyer HL, Geschwindt RD, Glover CL, Tran L, Hellstrom I, Hellstrom KE, et al. MESOMARK: a potential test for malignant pleural mesothelioma. Clin Chem 2007; 53:666 - 672
  • Di Serio F, Fontana A, Loizzi M, Capotorto G, Maggiolini P, Mera E, et al. Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results. Clin Chem Lab Med 2007; 45:634 - 638
  • Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, et al. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Ann Thorac Surg 2008; 85:265 - 272
  • Scherpereel A, Grigoriu B, Conti M, Gey T, Gregoire M, Copin MC, et al. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med 2006; 173:1155 - 1160
  • Grigoriu BD, Scherpereel A, Devos P, Chahine B, Letourneux M, Lebailly P, et al. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin Cancer Res 2007; 13:2928 - 2935
  • Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, et al. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Chest 2007; 132:1239 - 1246
  • Cristaudo A, Foddis R, Vivaldi A, Guglielmi G, Dipalma N, Filiberti R, et al. Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer. Clin Cancer Res 2007; 13:5076 - 5081
  • Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, et al. Soluble mesothelin-related protein—a blood test for mesothelioma. Lung Cancer 2005; 49:109 - 111
  • Christensen B, Houseman EA, Godleski JJ, Marsit CJ, Longacker JL, Roelofs CR, et al. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res 2009; 69:227 - 234
  • Destro A, Ceresoli GL, Baryshnikova E, Garassino I, Zucali PA, De Vincenzo F, et al. Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up. Lung Cancer 2008; 59:369 - 376
  • Goto Y, Shinjo K, Kondo Y, Shen L, Toyota M, Suzuki H, et al. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. Cancer Res 2009; 69:9073 - 9082
  • Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, et al. Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein. Occup Environ Med 2010; 67:233 - 236
  • Applebaum KM, Furniss CS, Zeka A, Posner MR, Smith JF, Bryan J, et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 2007; 99:1801 - 1810
  • Schneider J, Hoffmann H, Dienemann H, Herth FJ, Meister M, Muley T. Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer. J Thorac Oncol 2008; 3:1317 - 1324
  • Tan K, Kajino K, Momose S, Masaoka A, Sasahara K, Shiomi K, et al. Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter. Hum Pathol 2010; 41:1330 - 1338
  • Obulhasim G, Fujii H, Matsumoto T, Yasen M, Abe M, Matsuoka S, et al. Mesothelin gene expression and promoter methylation/hypomethylation in gynecological tumors. Eur J Gynaecol Oncol 2010; 31:63 - 71
  • Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003; 63:4158 - 4166

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.